WellTheory Raises $14M to Expand Autoimmune Care Platform
WellTheory's Series A round was led by General Catalyst and included participation from 7wireVentures, Ingeborg Investments, Accel, Box Group, Leaps by Bayer and Up2 Opportunity Fund.
WellTheory Secures $5M, Introduces New AI Tools to Support Autoimmune Care
WellTheory's $5 million raise included support from new investors Samsung Next, Opal Ventures and Up2 Fund, as well as existing investors Accel, OVO Fund and BoxGroup.
Transforming Clinical Content with Ambient & Generative AI
Sheila Bond, MD, talked about the latest trends regarding integration of AI in healthcare.
WellTheory Announces Women’s Health Program to Address Hormonal Conditions
WellTheory has launched a new program that will address the link between autoimmune disease and hormone imbalances.
Should New Entrants Bother With Selling Point Solutions To Employers?
Employers are struggling with point solution fatigue, but does that mean new startups shouldn't be selling to them anymore? Experts have mixed opinions.
‘An Opportunity to Catch Up’: Women’s Health Execs Applaud White House’s $100M Investment
Women's health advocates overwhelmingly came out in support of the White House's $100 million investment into women's health research. However, some noted shortcomings in where the funding is going.
‘I’ll Ask My Wife About This’: The Silly Things Women’s Health Entrepreneurs Hear From Male VCs
There are a lack of women at venture capital firms. This makes it difficult for women's health startups focused on stigmatized conditions to get funding when pitching to those who don't always have a good understanding, startups say.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
7 Hot Takes I Heard at HLTH
At HLTH 2023, I had dozens of conversations with providers, digital health investors, startup CEOs and other players in the healthcare industry. When I got home, I compiled seven refreshingly honest takes I heard from them while at the conference.